SUPN short interest
Supernus Pharmaceuticals Inc. · Healthcare · Drug Manufacturers - Specialty & Generic · settlement date 2026-09-30
| Shares short | 4,985,929 |
|---|---|
| Change vs prior report | -3,492 (-0.1%) |
| Change over six months | +10.0% |
| Days to cover | 7.38 (sector: 3.78) |
| Average daily volume | 675,999 |
| Rank in Healthcare | #220 of 922 by days to cover |
SUPN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 4,985,929 | -0.1% | 7.38 | 675,999 |
| 2026-09-15 | 4,989,421 | +6.8% | 8.65 | 576,525 |
| 2026-08-31 | 4,671,860 | +12.6% | 8.26 | 565,443 |
| 2026-08-14 | 4,147,629 | -13.9% | 2.80 | 1,481,103 |
| 2026-07-31 | 4,816,923 | -0.7% | 9.51 | 506,478 |
| 2026-07-15 | 4,850,861 | -32.1% | 5.12 | 947,818 |
| 2026-06-30 | 7,142,803 | +17.0% | 6.96 | 1,026,826 |
| 2026-06-15 | 6,103,430 | +12.6% | 10.12 | 602,836 |
| 2026-05-29 | 5,418,515 | +14.5% | 9.50 | 570,435 |
| 2026-05-15 | 4,731,258 | +0.2% | 5.29 | 894,396 |
| 2026-04-30 | 4,721,234 | -0.2% | 8.54 | 553,107 |
| 2026-04-15 | 4,732,523 | +4.4% | 9.31 | 508,067 |
| 2026-03-31 | 4,532,867 | +8.2% | 7.52 | 603,156 |
| 2026-03-13 | 4,188,850 | +2.6% | 6.51 | 643,739 |
| 2026-02-27 | 4,081,384 | +1.5% | 4.24 | 962,128 |
| 2026-02-13 | 4,021,038 | +0.8% | 5.70 | 705,359 |
| 2026-01-30 | 3,990,080 | -3.2% | 5.60 | 712,192 |
| 2026-01-15 | 4,122,399 | -6.0% | 6.55 | 629,426 |
| 2025-12-31 | 4,384,311 | -8.9% | 6.99 | 627,114 |
| 2025-12-15 | 4,812,734 | -3.6% | 8.14 | 591,043 |
| 2025-11-28 | 4,994,703 | -4.0% | 6.80 | 734,433 |
| 2025-11-14 | 5,202,679 | +6.8% | 3.68 | 1,413,026 |
| 2025-10-31 | 4,870,017 | -1.7% | 6.25 | 778,713 |
| 2025-10-15 | 4,954,765 | -4.5% | 6.24 | 794,110 |
| 2025-09-30 | 5,186,700 | +3.3% | 6.98 | 742,793 |
import finzdata as yf
yf.Ticker("SUPN").short_interest # every report since 2017
yf.Client().short_interest(["SUPN"], start="2018-01-01")Healthcare short interest · SUPN price history · Who owns SUPN · All short interest